Magazine issue

Stuck in the middleAs yet another year begins, we have to wonder whether the healthcare system on which we all rely...

Rainbow nation Including more people from different groups of society in clinical trials seems obvious now. Ten years...

Mad world We have all been doing a lot of squinting recently – trying to focus on the motley crew of politicians...

King-sized questWhen I spoke to you last month Boris Johnson was Prime Minister and HM Elizabeth II was Head of State....

Triumph of the heartThe greatest trick national governments ever played was to convince the people over which they...

Altogether nowPerhaps the one ‘silver lining’ from the healthcare tumult and pandemic chaos of the past couple of...

Let’s be honest, no one is really ‘destined’ to work in pharma – no one drifts of to sleep when they’re 17, dreaming...

Late expectationsIt’s fair to say that certain aspects of our industry have taken a while to change – in some cases...

Strange daysIn the past two years the battle against a faceless, merciless pandemic has raged throughout the world....

Pinching’s PathwayI always said that one day pharma would be unmasked, demystified and fully inducted into popular...

As we start 2022, there are hopes that COIVD-19 can be managed at last, thanks to the pharma industry’s swift vaccine...

With Christmas just around the corner, it is only natural to reflect on the changes and trends of 2021 as we move...

As we move firmly into winter, the NHS continues to deliver COVID-19 booster jabs at pace. However, with cases rising...

As the world gears up for COP26, climate change and sustainability have been brought into sharp focus once again, with...

With social distancing restrictions easing in the UK, it has never been more important to evaluate the ongoing and...